title: Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.
abstract: JL13 [5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5] benzoxazepine fumarate] is a substance with a close structural resemblance to clozapine. However, it is less sensitive to oxidation and may therefore have less hematological side effects. In the present study, JL13 was compared with clozapine and haloperidol in several animal models for schizophrenia. The paw test represents a screening model for antipsychotic drugs that can discriminate between drugs with extrapyramidal side effects and drugs without. Haloperidol increased both forelimb retraction time and hindlimb retraction time (HRT), whereas both clozapine and JL13 increased only HRT. In the prepulse inhibition paradigm, all three drugs reversed the apomorphine- and the amphetamine-induced disruption of prepulse inhibition. However, whereas haloperidol was equally effective against both dopaminergic drugs, JL13 and clozapine were more effective against amphetamine. Finally, only JL13 was able to increase prepulse inhibition in normal rats, whereas only clozapine reduced basal startle amplitude. Taken together, these data suggest that JL13 may be an effective antipsychotic drug, with a profile similar to clozapine.
authors.affiliation: Department of Psychoneuropharmacology, University of Nijmegen, The Netherlands.
authors.forename: B A
authors.initials: BA
authors.lastname: Ellenbroek
authors.forename: J F
authors.initials: JF
authors.lastname: Liégeois
authors.forename: J
authors.initials: J
authors.lastname: Bruhwyler
authors.forename: A R
authors.initials: AR
authors.lastname: Cools
mesh_terms: D000661:Amphetamine; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000737:chemistry; D000697:Central Nervous System Stimulants; D003024:Clozapine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use; D008124:Locomotion / Q000187:drug effects* / Q000502:physiology; D008297:Male; D011725:Pyridines / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar; D013216:Reflex, Startle / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D001570:Benzodiazepinones; D000697:Central Nervous System Stimulants; D011725:Pyridines; C003256:propizepine; C108260:JL 13 compound; D000661:Amphetamine; D003024:Clozapine; D006220:Haloperidol